Jaime L. Schneider

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract 5087: Projecting individualized probabilities of lifetime total cancer risk across a population

  Cancer Research · 2026-04-03

• Projecting Individualized Probabilities of Lifetime Total Cancer Risk Across a Population

  JCO oncology advances. · 2026-04-01

• Combination therapy with lorlatinib and mitogen-activated protein kinase pathway inhibition in previously treated ALK- or ROS1-rearranged lung cancer

  Lung Cancer · 2026-01-27

• Projecting individualized probabilities of lifetime all-cancer riskPreprint

  medRxiv · 2025-07-24

• PP01.01 Oncogenic Signaling is Rewired to Support Nucleotide Metabolism in Acquired Resistance to Targeted Therapies in NSCLC

  Journal of Thoracic Oncology · 2025-04-01

• Mass spectrometry methods and mathematical PK/PD model for decision tree-guided covalent drug development

  Nature Communications · 2025-02-19 · 3 citations

• GUK1 activation is a metabolic liability in lung cancer

  Cell · 2025-02-06 · 14 citations

• Fuel for thought: targeting metabolism in lung cancer

  Translational Lung Cancer Research · 2024-12-01 · 5 citations

• Advances and future directions in <i>ROS1</i> fusion-positive lung cancer

  The Oncologist · 2024-08-23 · 28 citations